Cardiac abnormalities in primary hyperoxaluria.

BACKGROUND In patients with primary hyperoxaluria (PH), oxalate overproduction can result in recurrent urolithiasis and nephrocalcinosis, which in some cases results in a progressive decline in renal function, oxalate retention, and systemic oxalosis involving bone, retina, arterial media, peripheral nerves, skin, and heart. Oxalosis involving the myocardium or conduction system can potentially lead to heart failure and fatal arrhythmias. METHODS AND RESULTS A retrospective review of our institution's database was conducted for all patients with a confirmed diagnosis of PH between 1/1948 and 1/2006 (n=103). Electrocardiogram (ECG) and echocardiography were used to identify cardiac abnormalities. Ninety-three patients fulfilled the inclusion criteria, 58% were male. Mean follow-up was 11.9 (median 8.8) years. In 38 patients who received an ECG or echocardiography, 31 were found to have any cardiac abnormalities. Cardiac findings correlated with decline in renal function. CONCLUSIONS Our data suggests that physicians caring for patients with PH should pay close attention to cardiac status, especially if renal function is impaired.

[1]  Jonas Crosby,et al.  Regional myocardial long-axis strain and strain rate measured by different tissue Doppler and speckle tracking echocardiography methods: a comparison with tagged magnetic resonance imaging. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[2]  Olivier Gerard,et al.  Assessment of subendocardial vs. subepicardial left ventricular rotation and twist using two-dimensional speckle tracking echocardiography: comparison with tagged cardiac magnetic resonance. , 2009, European heart journal.

[3]  S. Cha,et al.  Doppler strain imaging closely reflects myocardial energetic status in acute progressive ischemia and indicates energetic recovery after reperfusion. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[4]  S. Abdelwhab,et al.  Pulmonary Hypertension in Chronic Renal Failure Patients , 2008, American Journal of Nephrology.

[5]  Bijoy K Khandheria,et al.  Twist and untwist mechanics of the left ventricle. , 2008, Heart failure clinics.

[6]  S. Miyazaki,et al.  L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[7]  H. Shimokawa,et al.  Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[8]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[9]  G. Rumsby,et al.  Selected exonic sequencing of the AGXT gene provides a genetic diagnosis in 50% of patients with primary hyperoxaluria type 1. , 2007, Clinical chemistry.

[10]  J. De Sutter,et al.  Heart failure with mitral valve regurgitation due to primary hyperoxaluria type 1: case report with review of the literature , 2007, Acta cardiologica.

[11]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[12]  William Stewart,et al.  Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[13]  R. Wachter,et al.  Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II , 2006, Clinical Research in Cardiology.

[14]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[15]  E. Bergstralh,et al.  International Registry for Primary Hyperoxaluria , 2005, American Journal of Nephrology.

[16]  D. Milliner The Primary Hyperoxalurias: An Algorithm for Diagnosis , 2005, American Journal of Nephrology.

[17]  M. Coulter-Mackie,et al.  Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. , 2004, Kidney international.

[18]  L. Biblo,et al.  Type I Primary Hyperoxaluria: An Unusual Presentation of Ventricular Tachycardia , 2003, Cardiology in review.

[19]  B. Hoppe,et al.  A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria , 2003, Pediatric Nephrology.

[20]  D. Milliner,et al.  Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. , 2002, Kidney international.

[21]  M. Meurisse,et al.  Reversal of oxalosis cardiomyopathy after combined liver and kidney transplantation , 2002, Transplant international : official journal of the European Society for Organ Transplantation.

[22]  M. Hori,et al.  Echocardiographic Features in a Patient with Primary Oxalosis , 2001, Echocardiography.

[23]  B. Hoppe,et al.  The primary hyperoxalurias. , 2001, Journal of the American Society of Nephrology : JASN.

[24]  C. Langman The optimal approach to the patient with oxalosis. , 2001, Advances in renal replacement therapy.

[25]  E. Duhig,et al.  Primary oxalosis with cardiac involvement: echocardiographic features of an unusual form of cardiomyopathy. , 2001, Circulation.

[26]  J. Feingold,et al.  Estimating prevalence in single-gene kidney diseases progressing to renal failure. , 2000, Kidney international.

[27]  S. Cramer,et al.  The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. , 1999, Human molecular genetics.

[28]  B. Hoppe,et al.  Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria. , 1998, Kidney international.

[29]  J. Machac,et al.  Reversal of primary hyperoxaluria cardiomyopathy after combined liver and renal transplantation. , 1995, The American journal of cardiology.

[30]  P. Desmond,et al.  Primary hyperoxaluria type I. , 1994, Australasian radiology.

[31]  R. Watts Primary hyperoxaluria type I. , 1994, QJM : monthly journal of the Association of Physicians.

[32]  R. Rodby,et al.  Reversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-kidney transplantation. , 1991, The American journal of medicine.

[33]  C. Danpure Molecular and clinical heterogeneity in primary hyperoxaluria type 1. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  G. Devault,et al.  Reversal by liver transplantation of the complications of primary hyperoxaluria as well as the metabolic defect. , 1989, The New England journal of medicine.

[35]  B. Massie,et al.  Primary oxalosis with pan-conduction cardiac disease: electrophysiologic and anatomic correlation. , 1981, Circulation.

[36]  K. Hamaya,et al.  PRIMARY OXALOSIS WITH CARDIAC MANIFESTATIONS , 1980, Acta pathologica japonica.

[37]  A. Tonkin,et al.  Primary oxalosis with myocardial involvement and heart block. , 1976, The Medical journal of Australia.

[38]  Hutchins Gm,et al.  Adult-onset primary oxalosis with complete heart block. , 1973 .

[39]  R. Hudson,et al.  Primary oxalosis of the heart: a cause of heart block. , 1971, British heart journal.

[40]  Y. Ozaki,et al.  Long term prognosis of chronic heart failure: reduced vs preserved left ventricular ejection fraction. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[41]  D. Milliner,et al.  Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. , 2001, Kidney international.

[42]  S. Cramer,et al.  Erratum: The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II (Human Molecular Genetics (1999) 8 (2063-2069)) , 1999 .

[43]  Ronald J. Prineas,et al.  The Minnesota code manual of electrocardiographic findings : standards and procedures for measurement and classification , 1982 .

[44]  G. Hutchins,et al.  Adult-onset primary oxalosis with complete heart block. , 1973, The Johns Hopkins medical journal.